Elicio Therapeutics Analyst Ratings
Elicio Therapeutics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/26/2023 | 76.47% | HC Wainwright & Co. | → $12 | Assumes | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 2023 年 10 月 26 日 | 76.47% | HC Wainwright & Co. | → 12 美元 | 假设 | → 购买 |
What is the target price for Elicio Therapeutics (ELTX)?
Elicio Therapeutics（ELTX）的目标价格是多少？
The latest price target for Elicio Therapeutics (NASDAQ: ELTX) was reported by HC Wainwright & Co. on October 26, 2023. The analyst firm set a price target for $12.00 expecting ELTX to rise to within 12 months (a possible 76.47% upside). 1 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2023年10月26日公布了Elicio Therapeutics（纳斯达克股票代码：ELTX）的最新目标股价。该分析公司将目标股价定为12.00美元，预计ELTX将在12个月内上涨（可能上涨76.47％）。去年有1家分析公司公布了评级。
What is the most recent analyst rating for Elicio Therapeutics (ELTX)?
Elicio Therapeutics（ELTX）的最新分析师评级是多少？
The latest analyst rating for Elicio Therapeutics (NASDAQ: ELTX) was provided by HC Wainwright & Co., and Elicio Therapeutics their buy rating.
Elicio Therapeutics（纳斯达克股票代码：ELTX）的最新分析师评级由HC Wainwright & Co. 提供，Elicio Therapeutics的买入评级。
When is the next analyst rating going to be posted or updated for Elicio Therapeutics (ELTX)?
Elicio Therapeutics（ELTX）的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Elicio Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Elicio Therapeutics was filed on October 26, 2023 so you should expect the next rating to be made available sometime around October 26, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Elicio Therapeutics的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月进行一次评级，因此每家公司每年应获得4个评级。Elicio Therapeutics的最后一次评级是在2023年10月26日发布的，因此您应该预计下一个评级将在2024年10月26日左右公布。
Is the Analyst Rating Elicio Therapeutics (ELTX) correct?
分析师评级Elicio Therapeutics（ELTX）是否正确？
While ratings are subjective and will change, the latest Elicio Therapeutics (ELTX) rating was a with a price target of $0.00 to $12.00. The current price Elicio Therapeutics (ELTX) is trading at is $6.80, which is within the analyst's predicted range.
尽管评级是主观的，而且将发生变化，但最新的Elicio Therapeutics（ELTX）评级为A，目标股价为0.00美元至12.00美元。Elicio Therapeutics（ELTX）目前的交易价格为6.80美元，在分析师的预测区间内。